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Abstract
In this study we aim to determine, from body surface 
potential map (BSPM) data, the optimal bipolar chest
electrode placement for maximum R-wave amplitude. The 
study data consisted of 117-lead 352-node BSPM data 
recorded from 229 healthy subjects. The dataset was split 
into a training set of 172 subjects and a testing set of the 
remaining 57 subjects. Optimal electrode placement was 
determined using a lead selection method based on the 
difference in R-wave amplitude across all 352 nodes for 
each patient. R-wave values were then extracted and used 
to create a median BSPM of the training data. From this 
median BSPM the optimal electrode placement was 
defined as the location of the minimum and maximum R-
wave values. On the testing dataset this new optimal 
bipolar chest lead (R-lead) was then compared to all of the 
leads of the Mason-Likar 12-lead ECG and previously 
described bipolar chest leads, CM5, CS5, CC5 and CB5. The 
R-lead showed significant improvement in median R-wave
amplitude over the next best lead, CM5 (2562?? vs. 
2420????????oxon sign ranked test, p<0.001). Given the 
improvement in signal strength, an improvement in 
automated R-wave detection and R-R interval analysis
from single lead ECG monitors may be achieved. 
1? Introduction
Cardiac arrhythmias are common and can be 
associated with severe clinical events. An example of this 
is Atrial Fibrillation which has been shown to affect 
approximately 2% of the population and is associated with 
a significantly increase in the risk of stroke events [1].
Currently, if a patient is suspected of suffering from an 
arrhythmia they are given a 12-lead electrocardiogram 
(ECG). If the arrhythmia is not diagnosed on the 12-lead 
ECG, which can be the case with patients experiencing 
short intermittent arrhythmic episodes, continuous 
ambulatory ECG monitoring is usually performed. 
Ambulatory monitoring can be used for a number of 
different reasons, the most common being for the 
investigation of cardiac rhythm [2]. Over the past decade a 
number of new and novel devices for continuous 
ambulatory ECG monitoring have emerged.  These devices 
are mainly aimed for the detection of arrhythmias [3].
However, it is only now that new ambulatory ECG devices 
are being integrated into patient care and management.
These devices usually record a single-lead ECG and
incorporate automated algorithms to detect arrhythmias. A 
challenge faced by such ECG devices is the relatively low 
signal-to-noise ratio of the ECG in monitoring 
applications. The low signal-to-noise ratio can lead to false 
positive alarms [4]. The most common lead system used 
for recording of the ECG during exercise is the Mason-
Likar 12-lead ECG [5]. However the electrode locations 
associated with the ML 12-lead ECG interfere with 
echocardiography and defibrillation in a clinical setting
[6]. Also, the increased number of electrodes compared to 
single and three lead ECG systems and wires can reduce 
patient comfort.
Before multichannel ECG systems were readily 
available single-lead ambulatory ECG monitoring was 
commonly performed using bipolar chest lead (BCL) CS5.
This BCL is still commonly recorded today in certain 
clinical situations such as for example operating rooms [7].
In this study we aim to determine the optimal placement of 
bipolar ECG electrodes in order to obtain an ECG lead with 
maximized R-wave amplitude. In addition, we compared 
the performance of this new lead (R-lead) to all leads of 
the Mason-Likar (ML) 12-lead ECG and to a number of 
other previously described BCLs.
2? Ambulatory ECG lead systems
2.1? The Mason-Likar 12-lead ECG
In 1966, Mason and Likar discovered that when the limb 
electrodes were repositioned to more proximal locations on 
the torso the signal quality of the 12-lead ECG during 
exercise was greatly improved. The authors compared 
ECG recordings from the conventional 12-lead ECG to 
ECG recordings made with the limb electrodes being 
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moved progressively to more proximal positions up the 
arms and then over the upper anterior chest. They 
concluded the optimal electrode positioning for the limb 
electrodes was the right arm electrode placed on the 
infraclavicular fossa medial to the border of the deltoid 
muscle and 2cm below the lower border of the clavicle. 
The left arm electrode placed on the corresponding 
position and the left leg electrode placed on the anterior 
axillary line halfway between the costal margin and the 
iliac crest [2], [5]. The ML limb electrode positions are 
shown in Figure 1.
2.2? Bipolar chest leads
Before the ML 12-lead ECG was established as the gold 
standard for exercise ECG testing, BCLs were frequently 
utilized for the recording of exercise ECG data. These BCL 
leads are not commonly used in current day clinical 
practice.  This is  due to the suboptimal performance in 
detecting ST depression compared to multiple lead systems 
[8]. Previous work on BCLs has primarily focused on the 
analysis of the ST-T segment [9]–[11].  In addition, a
bipolar precordial lead recorded between V2 and V5 has
previously been shown to increase the sensitivity for the 
detection of type 1 Brugada pattern during ajmaline tests. 
The authors described this lead as lead V2-5 [12].  
Given the described improvement in lead-vector 
magnitude from BCLs [2], this may make them an 
appropriate choice for single-lead ambulatory ECG
monitors focused on assessing cardiac rhythm.
Figure 1. Electrode locations of the Mason-Likar 12-lead 
ECG (blue) and bipolar chest leads (green) for exercise 
testing. All bipolar chest leads are measured in respect to 
precordial lead V5 with the negative electrode placed in a 
range of different positions.
3? Method
3.1? Study data
The study population consisted of 117-lead BSPMs 
from 229 healthy subjects.  The BSPM data have 
previously been described in [13]. The BSPM-leads at the
117 recording sites were sampled with respect to Wilson’s 
central terminal. In order to provide greater spatial 
resolution, the 117-lead BSPMs were transformed, using a 
Laplacian 3D interpolation procedure, into 352-nodes 
which correspond to the nodes on the Dalhousie torso [14].
Some of the required electrocardiographic leads were 
not available as a direct subset of the interpolated BSPMs.  
Body surface potentials that were required but not 
available as a direct subset of the interpolated BSPMs were
obtained using linear interpolation. Random sampling was 
used to divide the study population into a training data set 
consisting of 172 patients and a testing data set consisting 
of the remaining 57 subjects.
3.2? Lead selection method
To determine a point in time were the maximum R-wave 
deflection occurred for each subject we calculated the 
difference in R-wave amplitude (?????) across all 352-
nodes of the BSPMs, as outlined below.
?????(?) =  ????(?) ? ????(?).  (1)
Were ?????(?) is the maximal R-wave amplitude for a 
defined point in time n,  ???? is the maximum R-wave 
value across all 352 BSPM nodes at n, ???? is the 
minimum R-wave value across all 352 BSPM nodes at n.  
The point in time containing the maximum R-wave 
amplitude for each subject was defined as location 
whereby the greatest difference in R-wave amplitude 
occured. R-wave values at this instance in time were then 
extracted across all 352-nodes. To alleviate any bias 
attributable to dominant R-wave values from individual 
subjects each subjects R-wave values were normalised 
between 0 and 1, as outlined below.
????? = ???????? (????)???  (????)???? (????). (2) 
Where ????? is the normalised R-waves value and 
???? is the non-normalised R-wave value. 
This method was repeated for all 172 subjects of the 
training set producing one BSPM, of R-wave amplitudes, 
for each subject. A population based R-wave BSPM was 
then produced by taking the median of the R-wave 
potentials on each node of the BSPM across all 172 
subjects of the training dataset, resulting in a single BSPM 
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of R-wave amplitudes across the population.
The median BSPM of the training dataset was used to 
determine the optimal BCL.  This optimal BCL was 
defined as the lead measured between the maximum and 
minimum R-wave amplitude locations.
3.3? Statistical analysis
The primary analysis compared the best lead for R-wave 
amplitude to the second best performing lead. A
comparison of the median R-wave amplitude values
between the different leads was performed using the 
Wilcoxon signed-rank test.  
4? Results
The optimal placement of bipolar electrodes for recording 
of maximum R-wave amplitude is the fourth left 
intercostal space adjacent to the sternum and the 5th left 
intercostal space on the mid clavicular line. These 
positions also correspond to precordial leads V2 and V5 of 
the 12-lead ECG. The R-lead showed significant 
improvement in median R-wave amplitude compared to 
the next best ECG lead, CM5 (2562?? vs. 2420????
Wilcoxon sign ranked test, p<0.001).
Figure 2. Median BSPM created from the training dataset (172 
patients).  A bipolar chest lead recorded between V2 and V5 can 
provide a significant improvement in R-wave amplitude across 
the testing dataset.  The optimal electrode placement highlighting 
in white with the remaining  four precordial leads mark in black.
Figure 3. R-wave amplitude from all investigated ECG leads. The R-lead outperformed all other leads in terms of median R-
wave amplitude (2562?? ???????????? ??????????????????????????p<0.001).
5? Discussion
Accurate automated detection of R-waves during high 
signal noise still remains a challenge. As such, many false 
positive alarms in a clinical setting can be made 
attributable to low R-wave amplitude and in turn low 
signal to noise ratio [15]. In this study we have focused on 
determining the optimal placement of ECG electrodes for 
the recording of maximum R-wave amplitude. The lead 
selection method implemented in this study analyses all 
available ECG information during ventricular 
depolarization to determine the point in time where the 
greatest R-wave amplitude occurred for each subject. The 
R-lead found in this study outperforms all other 
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investigated leads in terms of R-wave amplitude. The R-
lead could be used for applications such as long term 
ambulatory cardiac rhythm monitoring. Given the 
improvement in signal magnitude it is expected that an 
improvement in automated R-wave detection and 
improved R-R interval analysis may be possible. As the R-
lead is recorded between precordial lead V2 and V5 it can 
also be referred to as a bipolar precordial lead. What 
remains to be tested is the performance of the R-lead 
during events of myocardial ischemia. This will be of 
interest as BCLs CS5 and CM5 have been previously been 
described to detect up to 90% of all ST segment depression 
identified by multi-lead ECG systems [2][16]. 
6 Conclusion 
In situations where only a single lead ECG is available The 
R-lead can provide an improvement in the signal amplitude 
of the R-wave when compared to the ML 12-lead ECG and 
previously described BCLs. This new electrode position 
may lead to more accurate identification of R-peaks during 
times of high signal noise such as, for example, intense 
exercise.  
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